TNG908

News alerts, weekly reports and conference planners

Company:

Tango Therap

Drug class:

PRMT5 inhibitor

Related drugs:

MTAP deletion	Solid Tumor	MTAP deletion	Solid Tumor	TNG908 Sensitive: C2 – Inclusion Criteria TNG908 Sensitive : C2	TNG908 Sensitive: C2 – Inclusion Criteria TNG908 Sensitive : C2
MTAP deletion + KRAS G12C	Lung Adenocarcinoma	MTAP deletion + KRAS G12C	Lung Adenocarcinoma	sotorasib + TNG908 Sensitive: D – Preclinical sotorasib + TNG908 Sensitive : D	sotorasib + TNG908 Sensitive: D – Preclinical sotorasib + TNG908 Sensitive : D
MTAP deletion	Glioblastoma	MTAP deletion	Glioblastoma	TNG908 Sensitive: D – Preclinical TNG908 Sensitive : D	TNG908 Sensitive: D – Preclinical TNG908 Sensitive : D

Associations
(3)